Nemes Rush Group LLC
- SEC CIK
- 0001982273
- Latest filing
- Aug 14, 2026
ONCT holding history
Oncternal Therapeutics, Inc. in every 13F filed by Nemes Rush Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ONCT overviewAll 13F holders of ONCTFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q4 2024 | 3 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3 | $27 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3 | $23 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3 | $27 | <0.1% | +3 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −71−100.0% | Sold out | Holders |
| Q3 2023 | 71 | $22 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 71 | $25 | <0.1% | – | No prior filing | Holders |